Putting More Value Into Biopharmaceutical Value Assessments
Calls for prescription drug pricing transparency currently echo through state legislatures. Vermont, Maryland, and California have passed legislation requiring various aspects of prescription drug pricing to be made public. Numerous other legislative bodies are considering related efforts.
